Artisan Partners Portfolio holdings
AUM
$61.3B
1-Year Est. Return
26.25%
This Fund
S&P 500
1 Year Est. Return
+26.25%
AUM
$61.3B
AUM Growth
-$4.07B
(-6.2%)
Holding
365
Top Buys
| 1 | +$659M | |
| 2 | +$515M | |
| 3 | +$355M | |
| 4 |
Edwards Lifesciences
EW
|
+$333M |
| 5 |
IQVIA
IQV
|
+$329M |
Top Sells
| 1 | +$860M | |
| 2 | +$653M | |
| 3 | +$439M | |
| 4 |
Netflix
NFLX
|
+$365M |
| 5 |
Danaher
DHR
|
+$317M |
Sector Composition
| 1 | Financials | 26.49% |
| 2 | Healthcare | 18.86% |
| 3 | Technology | 17.27% |
| 4 | Industrials | 10.97% |
| 5 | Communication Services | 8.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Akamai
AKAM
$21.7B
| $20.4M | 0.03% |
+177,406
|
|
||
277
Constellation Brands
STZ
$23.9B
| $20.2M | 0.03% |
134,506
-16,133
|
|
||
|
HSAI
278
Hesai Group
HSAI
$2.97B
| $19.7M | 0.03% |
1,031,044
+184,818
|
|
||
279
Expeditors International
EXPD
$20.7B
| $19.4M | 0.03% |
135,133
-9,329
|
|
||
280
Zegna
ZGN
$3.94B
| $19.2M | 0.03% |
1,840,151
-90,197
|
|
||
281
BridgeBio Pharma
BBIO
$13B
| $18.9M | 0.03% |
254,392
-24,675
|
|
||
282
Luxfer Holdings
LXFR
$460M
| $18.3M | 0.03% |
1,504,665
-195,885
|
|
||
283
Freshpet
FRPT
$2.54B
| $17.6M | 0.03% |
+298,914
|
|
||
284
MGM Resorts International
MGM
$11.2B
| $17.5M | 0.03% |
472,188
-53,699
|
|
||
285
Vaxcyte
PCVX
$7.42B
| $17.3M | 0.03% |
297,432
-6,617
|
|
||
286
Agios Pharmaceuticals
AGIO
$1.75B
| $16.3M | 0.03% |
481,516
-22,969
|
|
||
|
YSS
287
York Space Systems
YSS
$4.23B
| $15.6M | 0.03% |
+705,746
|
|
||
288
Masco
MAS
$14.2B
| $14.8M | 0.02% |
+245,251
|
|
||
289
T-Mobile US
TMUS
$203B
| $14.3M | 0.02% |
+68,323
|
|
||
290
RxSight
RXST
$221M
| $12.7M | 0.02% |
2,058,684
-98,580
|
|
||
291
Dyne Therapeutics
DYN
$3.2B
| $11.2M | 0.02% |
619,457
-30,234
|
|
||
|
ARIS
292
Aris Mining
ARIS
$3.74B
| $10.9M | 0.02% |
584,370
+88,130
|
|
||
|
LINE
293
Lineage Inc
LINE
$10.1B
| $10.8M | 0.02% |
329,491
+34,571
|
|
||
294
Globant
GLOB
$1.74B
| $10.4M | 0.02% |
225,877
+18,967
|
|
||
295
Stoke Therapeutics
STOK
$1.93B
| $10.3M | 0.02% |
+315,492
|
|
||
296
Amdocs
DOX
$6.69B
| $9.16M | 0.01% |
140,326
-10,854
|
|
||
|
VG
297
Venture Global Inc
VG
$29.9B
| $8.03M | 0.01% |
+509,534
|
|
||
298
iShares MSCI India ETF
INDA
$6.78B
| $7.86M | 0.01% |
167,700
+42,246
|
|
||
299
Ocular Therapeutix
OCUL
$1.97B
| $7.65M | 0.01% |
902,931
-160,440
|
|
||
300
Moelis & Co
MC
$5B
| $7.32M | 0.01% |
128,399
-215,598
|
|